X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-09-11 | SNSE | Celebi John | Pres, CEO | P - Purchase | $0.85 | +500 | 111,311 | 0% | +$425 | ||||||
2023-06-01 | SNSE | Apeiron Investment Group Ltd. | 10% | S - Sale | $1.58 | -3,441,661 | 0 | -100% | -$5,437,824 | ||||||
2023-02-23 | SNSE | Apeiron Investment Group Ltd. | 10% | P - Purchase | $1.61 | +2,200 | 3,441,661 | 0% | +$3,539 | ||||||
A | 2022-03-02 | SNSE | Peyer James | Dir, 10% | P - Purchase | $3.20 | +1,203 | 5,231,488 | 0% | +$3,850 | |||||
A | 2022-03-02 | SNSE | Cambrian Biopharma Inc | 10% | P - Purchase | $3.20 | +1,203 | 5,231,488 | 0% | +$3,850 | |||||
A | 2021-03-23 | SNSE | Peyer James | Dir, 10% | P - Purchase | $14.34 | +9,500 | 4,798,293 | 0% | +$136,230 | |||||
A | 2021-02-18 | SNSE | Peyer James | Dir, 10% | P - Purchase | $19.75 | +752 | 4,690,905 | 0% | +$14,852 | |||||
A | 2021-03-23 | SNSE | Cambrian Biopharma Inc | 10% | P - Purchase | $14.34 | +9,500 | 4,798,293 | 0% | +$136,230 | |||||
A | 2021-02-18 | SNSE | Cambrian Biopharma Inc | 10% | P - Purchase | $19.75 | +752 | 4,690,905 | 0% | +$14,852 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |